Company Filing History:
Years Active: 2007
Title: Jo Ann Horowitz: A Pioneer in Cancer Treatment Innovations
Introduction
Jo Ann Horowitz, an innovative inventor based in Kenilworth, NJ, has made significant contributions to the field of cancer treatment. With a patent that seeks to enhance therapeutic strategies for combatting neoplasms, her work represents a fusion of cutting-edge science and a deep commitment to improving patient outcomes.
Latest Patents
Horowitz holds a patent for a revolutionary method titled "Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms." This groundbreaking invention outlines a method for treating mammalian cancer or hyperproliferative cells by utilizing a combination of tumor suppressor proteins or nucleic acids alongside adjunctive anti-cancer agents. The patent also describes a pharmacological composition that includes these components, along with a kit designed for practical application in treating cancerous cells.
Career Highlights
Throughout her career, Jo Ann Horowitz has established herself as a leading figure in the realm of cancer research and treatment. Her work at Canji Inc. is particularly noteworthy, as she collaborates with other esteemed professionals to drive forward vital advancements in medical science. Her innovative approach bridges the gap between basic research and practical applications in oncology.
Collaborations
At Canji Inc., Jo Ann has had the privilege of working alongside talented individuals such as Loretta Nielsen and Daniel C Maneval. These collaborations foster an environment of creativity and support within the team, contributing to their shared goal of developing effective cancer therapies. The synergy of expertise among these professionals amplifies the impact of their research and drives innovations in the field.
Conclusion
Jo Ann Horowitz's contributions to cancer treatment exemplify the power of innovation and collaboration. Her patented method of combining tumor suppressor therapies with conventional chemotherapy represents a promising advancement in the fight against cancer. As she continues to work alongside her colleagues at Canji Inc., the potential for transformative breakthroughs in oncology remains bright.